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Background: Genomic structure variation (GSV) is widely distributed in various organisms and is an important
contributor to human diversity and disease susceptibility. Efficient approaches to induce targeted genomic structure
variation are crucial for both analytic and therapeutic studies of GSV. Here, we presented an efficient strategy to
induce targeted GSV including chromosomal deletions, duplications and inversions in a precise manner.
Results: Utilizing Transcription Activator-Like Effector Nucleases (TALEN) designed to target two distinct sites, we
demonstrated targeted deletions, duplications and inversions of an 8.9 Mb chromosomal segment, which is about
one third of the entire chromosome. We developed a novel method by combining TALEN-induced GSV and single
stranded oligodeoxynucleotide (ssODN) mediated gene modifications to reduce unwanted mutations occurring
during the targeted GSV using TALEN or Zinc finger nuclease (ZFN). Furthermore, we showed that co-introduction of
TALEN and ssODN generated unwanted complex structure variation other than the expected chromosomal deletion.
Conclusions: We demonstrated the ability of TALEN to induce targeted GSV and provided an efficient strategy to
perform GSV precisely. Furthermore, it is the first time to show that co-introduction of TALEN and ssODN
generated unwanted complex structure variation. It is plausible to believe that the strategies developed in this
study can be applied to other organisms, and will help understand the biological roles of GSV and therapeutic
applications of TALEN and ssODN.
Keywords: TAL Effectors, Genomic structure variation, Chromosomal deletion, Chromosomal duplication,
Chromosomal inversion, ssODNBackground
Genomic structure variations (GSVs), including chromo-
somal deletions, duplications, inversions, insertions and
translocations, are one of the most important contributors
to genetic diversity and often associated with diseases and
cancers [1-5]. To reveal the landscape of genetic variation
in human or various organisms, several methods including
next-generation sequencing and paired-end mapping have
been developed to detect and characterise GSV [6]. How-
ever, the relationship between GSV and phenotypic conse-
quence remains unclear. Efficient approaches to induce
targeted GSV are crucial for studying this relationship and
for practicing personalized gene therapy. Approaches* Correspondence: xiaqy@swu.edu.cn
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stated.to generate targeted translocations [7,8], deletions [5], or du-
plications and inversions [5] of genomic segments in human
cells have been developed by generating two double strand
breaks (DSB) utilizing two pairs of engineered ZFN. But the
outcomes of induced GSV in a population varied greatly
among the progeny, suggested that the non-homologous
end joining (NHEJ) repair of ZFN induced DSB would pro-
duce multiple, unpredicted mutations. Therefore, induction
of GSV directly using this strategy is undesirable in funda-
mental studies and risky in gene therapy. Oligonucleotide-
based gene modification is a site specific genome editing
strategy utilizing triplex-forming oligonucleotide or
single-stranded oligodeoxynucleotide and has been shown
to successfully mediate modification of genomic DNA in
mammalian cells in a precise sequence-specific manner
[9], but with much lower efficiency.
Generally, it is challenging to generate custom ZFNs
with high specificity and activity from non-commercial. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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method, has proved to be a more accessible genetic ma-
nipulation tool since TALENs can readily be manufactured
in academic research labs with common existing molecular
biology reagents and expertise [10]. We previously showed
that two pairs of TALENs could also induce a heritable
792 bp chromosomal deletion in silkworm, Bombyx mori,
in a similar manner of ZFN in human cell lines [11]. Tar-
geted 7 kb deletions and inversions using TALEN were also
demonstrated in livestock [12]. These studies suggested that
TALEN can serve as a more powerful tool to induce tar-
geted GSV. Also, various strategies to construct custom
TALEN have been established, including standard restric-
tion enzyme and ligation-based cloning, ‘Golden Gate’ clon-
ing, solid-phase assembly and ligation independent cloning
technique for both single TALEN construction and high
throughput assembly [13-15]. Generating an active TALEN
pair is feasible for any researcher who is familiar with con-
ventional molecular cloning. We proposed that a combin-
ation of TALEN induced DSB and Oligonucleotide-based
gene modification induce targeted GSV in a predictable,
precise sequence specific manner.
To verify our hypothesis, we constructed an active
TALEN targeted to an endogenous gene (Bm702), which
is 8.9 Mb downstream BmBlos2 and induced targeted
GSV in silkworm embryos. Our results revealed that: (1)
simultaneous expression of two TALENs could induce
targeted genomic deletions, inversions and duplications,
and (2) addition of ssODN could reduce unwanted mu-
tations. In addition, delivery of additional TALEN into
the organism may increase the possibility of off-target
cleavage, which is the major concern of hybrid nucleases
mediated genome editing. We also tested the possibility
of chromosomal deletions using one pair of TALEN to-
gether with an ssODN.
Results
High genome editing activity of TALEN-702 in vivo
Previously we have constructed two active TALENs tar-
geting the 2nd exon and the 3rd exon of BmBlos2, termed
TALEN-B2 and TALEN-B3 in this study. The results
showed that simultaneous expression in silkworm em-
bryos could generate heritable 792 bp chromosome dele-
tions [11]. To test whether TALEN can induce GSV such
as genomic deletions, inversions and duplications with a
large chromosomal fragment, we selected Bm702, an en-
dogenous gene located 8.9 Mb downstream of BmBlos2 as
a target gene to generate additional TALEN (Figure 1a).
To test the activity of TALEN-702, a 48 bp recognition
site was cloned into the pSSA-Luc vector. The insertion
site was between two truncated luciferase fragments. The
vector was transfected into human embryonic kidney
(HEK) 293 T cells with or without transcribed TALEN-702
mRNA in vitro. Luciferase activity of co-transfection ofTALEN-702 and SSA reporter vector detected 24 h post-
transfection showed a 28-fold increase, compared with
transfection of SSA reporter vector only (Figure 2A), which
suggested that TALEN-702 has a high activity to promote
homologous recombination (HR) events in HEK 293 T
cells. As SSA recombination assay is based on the HR re-
pair pathway, and targeted GSV relies on the NHEJ repair
pathway, T7 Endonuclease I digestion (T7EI) assay was
then conducted to demonstrate that the repair of TALEN-
induced DSB was through the NHEJ repair pathway.
TALEN-702 mRNA was microinjected into about 100 silk-
worm embryos. To detect NHEJ events, PCR product using
primers flanking the endogenous TALEN-702 cleavage site
(702 F-883 and 702R-611, Additional file 1: Table S2) was
subjected to T7 Endonuclease I digestion. The length from
forward and reverse primer to TALEN-702 cleavage site is
883 and 611 bp, respectively, so the PCR product can be
digested into two fragments (883 and 611 bp) only if NHEJ
events occur at TALEN-702 cleavage site. The result
showed that TALEN-702 could induce efficient mutations
in the endogenous gene loci through NHEJ repair pathway
(Figure 2B). However, the accurate mutation frequency
can not be measured because of the existence of SNP
bands (about 1000 and 500 bp, Figure 2B).
Large chromosomal structure variation mediated by
TALEN-B2 and TALEN-702
Previously we have shown that co-expression of TALEN-
B2 and TALEN-B3 could induce a heritable 792 bp
chromosomal deletion [11]. To test whether such deletion
can occur between two DSBs whose distance is much lar-
ger, and whether co-expression of two distant TALENs
can induce chromosomal inversions and duplications,
in vitro transcribed mRNA of TALEN-B2 and TALEN-
702 were mixed and microinjected into about 100 silk-
worm embryos. PCR was performed using genomic DNA
from pooled embryos 3 day after microinjection and spe-
cific primers to detect genomic deletions, duplications and
inversions. As shown in Figure 3, all primers designed to
detect 8.9 Mb deletions, duplications and inversions could
amplify products with expected size from genomic DNA
of injected embryos (Figure 3B), but not un-injected
(Figure 3A). Compared with bands of native locus,
bands of induced GSV products are much weaker, but
they still can be detected easily at various PCR conditions
(data not shown), indicating a considerable frequency. To
further confirm the targeted GSV, we cloned the PCR
products and determined their sequences. The results
showed that 5′ portion of the 2nd exon of BmBlos2 was
directly joined to 3′ portion of the 2nd exon of Bm702 in
the deletion events; 5′ portion of the 2nd exon of Bm702
was directly joined to 3′ portion of the 2nd exon of
BmBlos2 in duplication events; 5′ portion of the 2nd exon
of BmBlos2 were joined to inverted 5′ portion of the 2nd
Figure 2 Genome editing activity of TALEN-702. (A) In vivo analysis of TALEN activity in HEK 293 T cells using a luciferase reporter system. The
entire TALEN-702 recognition site was cloned into a pSSA-Luc vector and transfected into HEK 293 T cell with (TALEN-702) or without (control)
in vitro transcribed TALEN-702 mRNA. Luciferase activity was detected 24 hours post transfection. (B) Transient assay of TALEN activity in silkworm
embryos using T7EI assay. PCR was performed using primer 702 F-883 and 702R-611 using genomic DNA from un-injected embryos (lane 2 and 3)
or injected embryos (lane 4 and 5). M represents DNA ladders, the letters on the left indicate length of each band.
Figure 1 Design of TALENs that target the BGIBMGA000702 gene. (a) Schematic representation of the silkworm chromosome 1 and
position of BmBlos2 gene and Bm702 gene. Brown box represents the entire chromosome and blue boxes below represent scaffolds mapped to
chromosome one. The position of BmBlos2 gene and Bm702 gene are indicated by oblique lines. Exon 2 of each gene is indicated by a black
box. Blue and red arrows represent the position of TALEN recognition sites for BmBlos2 gene and Bm702 gene, respectively. Black arrows and
letters below them represent the position and names of primers used to detect mutations. (b) Schematic representation of TALEN proteins. A
triple flag tag (light green boxes) and a nuclear localization signal (NLS) (purple boxes) are fused to TALE domain (yellow boxes) of each TALEN
monomer. The FokI domain (red boxes) is linked to the TALE domain through a flexible linker. (c) TALEN target sequences and the corresponding
RVDs within each repeat. The entire TALEN recognition sequence is shown on the top, in which underlined sequence represents the recognition
site of the corresponding TALEN monomer. RVDs utilized for each TALEN monomer are shown on the bottom. The number at the top of the left
panel indicates the position of the repeat. The letters at the top of each TALEN monomer represent the target sequence and the letters below
represent the RVDs of the corresponding repeat.




Figure 3 Detection of large chromosomal structural variation. (A and B) PCR was performed using primer set to detect chromosomal deletion
(lane 4), duplication (lane 5), and inversions (lane 6 and 7) from genomic DNA of un-injected embryos (A) and injected embryos (B). For comparison,
primer sets to amplify the flanking regions of TALEN-702 site (lane 2) and TALEN-B2 site (lane 3) were also used. M represents DNA ladders, the letters
on the left indicate length of each band. (C) Sequences of the PCR products. The wild-type sequence is shown at the top with the full TALEN-B2 site
in blue and the TALEN-702 site in red. The TALEN recognition sites are underlined, and deletions are indicated by dashed lines.
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events, small indels were observed at the breakpoint junc-
tions, suggesting that TALEN-induced GSV through NHEJ
repair pathway is not a precise approach.
Precise GSV using TALEN and ssODNs
In most cases, mutations such as small indels are not
wanted. To verify our hypothesis that introduction of a
well designed ssODN will guide the targeted GSV into a
more precise manner, two ssODNs (B702-DE and B702-
IN, Additional file 1: Table S2) were designed and synthe-
sized. To distinguish ssODN guided modifications from
natural DNA repair pathways, an additional sequence
“TTAT” was introduced into the B702-DE and a nucleo-
tide (T) was deleted in the right TALEN-B2 binding site
of B702-IN. B702-DE was co-injected with TALEN-B2
and TALEN-702 into about 100 silkworm embryos. PCR
application was performed using specific primers to detect
potential deletions from genomic DNA of injected em-
bryos. Similarly, B702-IN was co-injected with TALEN-B2
and TALEN-702 and PCR was performed to detect po-
tential inversions. The PCR products were cloned and
sequenced. Compared with injection of TALEN-B2 and
TALEN-702, the addition of ssODN significantly re-
duced the unwanted mutations (Figure 4).
Heritable chromosomal deletions using a pair of TALENs
and ssODN
Although TALEN was reported to be sequence-specific,
off-target cleavages were also observed [16]. We havedemonstrated that co-expression of two TALENs could
induce targeted GSV, however, this strategy involves the
introduction of an additional TALEN as compared to
the conventional site directed mutagenesis, which uses
only one TALEN. In our case, any combination of the
four half target site of TALEN-B2 and TALEN-702 don’t
have homologous sequences within the entire silkworm
genome, so we didn’t check the off-target cleavage activity.
In general, involving of an additional TALEN would of
course greatly increase the possibility of off target cleav-
age, even when obligated FokI variants are utilized. Chen
et al. [17] used ssODN in tandem with a pair of ZFN to
efficiently produce human cell lines with targeted genomic
deletion in a defined manner. To perform large precise
deletions through TALENs, we tested the possibility of
combining TALEN with ssODN. An ssODN composed
of a 60 nt sequence distal (794 bp) to the B3 cleavage
site, followed by a 40 nt sequence containing B3 right
site (Additional file 1: Table S2), was synthesized and
co-injected with TALEN-B3 mRNAs into 402 silkworm
embryos. Only one mosaic mutation was observed from
35 hatched G0 silkworm larvae (Figure 5A, Additional
file 1: Table S1). Twenty one G0 larvae successfully devel-
oped to moths to produce 11 G1 silkworm broods and 21
moths were subjected to genomic DNA extraction and
PCR amplification of the fragment containing two tar-
get sites and intervening sequences. Interestingly, we
observed a small amplified DNA segments with the ex-
pected size from the mosaic, but not the other 20 silk-
worms (Additional file 1: Figure S1). Sequencing of the
Figure 4 Precisely chromosomal deletions and inversions using TALEN and ssODNs. B702-IN and B702-DE were injected with a mixture of
two TALENs separately. Sequences are aligned as described in Figure 3C. Sequences equal to designed ssODNs were labelled by green arrows
and their percentages among total sequenced clone were shown in the column chart.
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from the genome as expected.
Genetic and molecular analysis of ssODN-mediated
mutations
To test whether this ssODN mediated 794 bp chromo-
somal deletions was heritable, about 3000 silkworms
from 11 G1 broods were reared and allowed to develop
to the 3rd instar. Five silkworms with translucent skin
phenotype were obtained from the brood whose male
parent was mosaic (Figure 5B). This was in accordance
with that mosaic G0 moths are more likely to produce
mutant G1 individuals, which we also observed in our
previous studies [11]. The results suggested that ssODN
mediated chromosomal deletions was heritable, although
at a very low frequency (about 9.1% for broods and 1.7%
for individuals). To check whether the G1 mutants were
caused by TALEN-B3 only or TALEN-B3 together with
ssODN, 5 G1 mutants were allowed to develop to
moths and subjected to genomic DNA extraction after
mating. Genomic PCR (primers: B2-F241 and R315)
results (Figure 5C) showed that two individuals (NO.1
and NO.3) were small indels induced by TALEN-B3only. Neither native bands nor deletion bands were de-
tected in two individuals (NO.2 and NO.5), suggesting
that there might be some unknown complex chromo-
somal rearrangements at this locus in these two indi-
viduals. Interestingly but unfortunately, these two
individuals failed to produce any offspring, and gen-
omic DNA from G1 individuals were not good enough
to perform more experiments such as southern blot-
ting to determine the exact sequence change in this re-
gion. To our surprise, two bands were detected in one
individual (NO.4), the smaller one of which was with
the same size as the deletion band and the larger one
was slightly larger than the native band (Figure 5C and D).
As all the 5 G1 mutants were female and should have only
one Z chromosome, we suspected that NO.4 individual
might also be a consequence of a complex chromosomal
rearrangement event.
Discussion
Approximately 5% of the human genome was defined as
structurally variant in the normal population, involving
more than 800 independent genes [18]. Structural variation
can comprise millions of nucleotides of heterogeneity
Figure 5 Large chromosomal deletions using a pair of TALENs and ssODN. (A) Mosaic mutations induced by co-injection of TALEN-B3 and
ssODN. Silkworms were reared on fresh mulberry leaves. (B) Images of germline mutations from the dorsal side (left panel) and the lateral side
(right panel). The worm on the left in each panel is wild type silkworm. Silkworms were reared on artificial diet. The scale bar represents 1 cm.
(C) Gel analysis of PCR amplifications using primers B2-F241 and B3-R315 from genomic DNA of 5 G1 mutant individuals (numbers 1 to 5). M
represents the DNA ladders, the letters on the left indicate length of each band. (D) Gel analysis of PCR amplifications using genomic DNA of
wild type (panel indicated as 1 to 3) and G2 mutant silkworm from NO. 4 G1 mutants (panel indicated as 4 to 6). Primer sets are shown on the
top of each panel.
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ant contribution to human diversity and disease sus-
ceptibility [19]. As the rapid progress of genome
sequencing and bioinformatics tools, GSV has been
identified in more and more genomes of various organ-
isms including animals and plants. Targeted induction
of certain GSV such as deletion, duplication and inversion
is one of the most important tasks of genome editing for
both analytic and therapeutic purposes. Compared with
conventional gene targeting such as site directed muta-
genesis (knockout), gene correction and addition, targeted
GSV can be used to reveal the relationship between nat-
ural occurred GSV and its phenotypic impact, and to be
used as powerful genetic manipulation tools to reengineer
large chromosomal segments such as regulatory elements,
non-coding RNAs and transgenes.
In recent years, genetic manipulation was greatly revolu-
tionized as the emergence of ZFN and TALEN, as well as
the newly emerged RNA-mediated genome editing tools
[20-22]. It is much easier and faster to generate site spe-
cific knock-out organisms for both model and non-modelsystems. At the same time, the ability to induce targeted
GSV has also been demonstrated in human cells [5,9,23,24]
and in tobacco [25] using two pairs of ZFN, in human cells
using a pair of ZFN together with ssODN [17], in silkworm
and live stock using two pairs of TALEN [11,12] and in
zebrafish using ZFN and TALEN [26]. However, more evi-
dences are needed to address the questions raised by these
pioneered studies and those uncovered issues.
Although ZFN and TALEN contain the same FokI
nuclease domain and function in a similar way to induce
mutations, it was observed that ZFN and TALEN were
associated with different mutation patterns [11,27].
Successful targeted chromosomal deletions, duplications
and inversions using ZFN [5,9,23-25] prompt us to inves-
tigate the possibility of targeted GSV using TALEN. We
have previously shown that simultaneous expression of
two TALENs could mediate heritable 792 bp segment de-
letion in silkworm, B. mori [11], which was also supported
by similar investigations in livestock [12] and zebrafish
[26]. In the present study, we generated an active TALEN
targeting to an endogenous gene, Bm702, which is about
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these two TALENs, we demonstrated that chromosomal
deletions and inversions could be obtained at a considerable
frequency, and targeted chromosomal duplications were
also detected, which was not demonstrated before using
TALEN. As there are too many genes in the 8.9 Mb re-
gion, it is nearly impossible for us to detect whether
these modifications are heritable. However, the observed
mutation efficiency should be high enough to generate
heritable mutations according to our experience in silk-
worm. Our results in the present study, together with
those reported previously [11,12,26], provided an alternative
or even better tool for targeted GSV. To reduce unwanted
mutations in the targeted GSV outcomes, which are unex-
pected in both fundamental studies and therapeutic ap-
plications, we combined the TALEN-induced GSV and
ssODN mediated gene modifications. Despite the fact that
not 100% of the mutant sequences were expected, TALEN-
induced GSV was observed to work in a more precise
manner after introduction of well designed ssODN.
Although at a very low efficiency, it is encouraging to
observe targeted chromosomal deletion using TALEN-
B3 and B3-794 in somatic cell of silkworm, suggesting
that this strategy can also work withTALEN. Unfortunately,
none of the five heritable mutants showed the expected
genotype. Instead, two of them were mutants generated by
TALEN-B3 only and the other three exhibit abnormal
chromosomal rearrangements. We speculate that the differ-
ence between precise chromosomal deletion demonstrated
in human cells [17] and unpredictable outcomes observed
in our studies might due to the following reasons. (1) Com-
pared with 5 or 6 bp spacers of ZFN, TALEN-B3 has a
much larger size of spacer (16 bp). Generally, larger spacers
are easier to generate heterogeneous overhangs than the
well defined 4- or 5-bp overhangs produced by ZFN [28]. It
is demonstrated that defined overhangs may facilitate tar-
geted insertions of plasmid DNA at genomic sites [29]. (2)
Neither ZFN nor TALEN was demonstrated to work with
ssODN to generate precise large chromosomal deletions in
organisms other than human cell lines. It is possible but
not probable that this mechanism doesn’t work in insect
species and perhaps other organisms. However, further in-
vestigations are needed to demonstrate the above possibil-
ities. This finding also raises a concern about gene therapy,
that hybrid nucleases and ssODN, both of which are
thought to be or have been used in gene therapy [30,31],
may induce unwanted chromosomal changes.
Conclusion
In summary, we demonstrated the ability of 2 pairs of
TALEN to induce GSV including deletion, duplication
and inversion of a chromosomal fragment as large as
8.9 Mb, which is about one third of the entire chromo-
some, and developed an efficient strategy to reduce theunwanted mutations during structure variation by add-
ing ssODN. Furthermore, it is the first time to show in
this study that co-introduction of one pair of TALEN
and ssODN may generate complex structure changes
other than the expected chromosomal deletion. Al-
though most of the experiments were conducted in silk-
worm, B. mori, a research model Lepidoptera insect, the
DNA repair pathways that contend with DNA damage
are highly conserved in all living organisms [32,33], and
the mechanism of TALEN-induced mutation is thought
to be identical in different biological systems. Thus it is
plausible to believe that the strategies developed in this
study can be applied to other organisms, and will help
understand the biological roles of GSV and therapeutic
applications of TALEN.
Methods
Design and construction of TALEN-702
The sequence of the 2nd exon of Bm702 was subjected to
a web-based designer tool (http://zifit.partners.org/ZiFiT/
Disclaimer.aspx) to design the target site. To avoid poten-
tial off-target cleavage, potential sites were aligned to silk-
worm genome sequence to remove those sequence with
homologous in the genome. A 48 bp target sequence
was selected, and the corresponding TALEN sequence
(TALEN-702 L and TALEN-702R) were generated using
backbone as described previously [11] and repeat variable
di-residue (RVD) following the rules that NG, HD, NI, and
NN recognize T, C, A, and G, respectively (Figure 1b and c).
The assembly of TAL effector domain was completed
through a commercial service (ViewSolid Biotech).
mRNA synthesis
Plasmid vectors TALEN-702 L and TALEN-702R were
prepared using a plasmid midi kit (QiaGen), digested
with XbaI (NEB) and phenol/chloroform purified. in vitro
transcription was performed using MessageMax™ T7
ARCA-capped Message Transcription Kit (Epicentre Bio-
technologies). Cap RNA was then polyadenylated using the
Poly (A) Polymerase Tailing Kit (Epicentre Biotechnologies).
The resulting mRNA was purified using the MegaClear Kit
(Ambion) and quantified using a NanoDrop-2000 (Thermo
Scientific). mRNA was dissolved in RNAse-free water
(Sigma-Aldrich) to a concentration of 500 ng/μl. TALEN-
702 L and TALEN-702R mRNA were mixed at a molar
ratio of 1:1 and stored at -80°C.
Luciferase single-strand annealing (SSA) reporter gene assay
The luciferase SSA assay was performed as described
elsewhere [15]. The template plasmid containing TALEN-
702 target site was generated by PCR-based mutagen-
esis using a primer containing 48 bp target site at
the 5′ portion. The HEK 293 T cell line, which is
widely used as an in vitro model system for transfection
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from View-solid Biotech. The use of HEK 293 T cell
line was approved by the institutional Ethics Committees
of our university and conducted in accordance with the
ethical guidelines of the Declaration of Helsinki.
Microinjection of silkworm embryos
A diapausing strain, Dazao, which is wildly used as a
wild type silkworm, was utilized in this study. The larvae
were reared with fresh mulberry leaves at 25°C, 75% RH.
Parental embryos (P) were incubated at 15°C and 75%
RH to produce nondiapusing eggs (G0), which are suit-
able for microinjection. The microinjections were per-
formed utilizing TransferMan NK2 micromanipulator
and Femto Jet 5247 microinjector (Eppendorf ) under an
SZX16 microscope (Olympus) as we reported previously
[11]. For transient assays, embryos were injected within
5 hours after oviposition and harvested 3 days post injec-
tions. For germline assays such as heritable chromosomal
deletion using TALEN-B3 and ssODN B3-794, embryos
were injected within 2 hours after oviposition and allowed
to develop to moths. Mosaic mutations were observed as
early as the 3rd instar. The resulting G0 males were first
crossed with G0 females and the remaining uncopulated
G0 males were crossed with wild-type females. The G1
mutations were checked for the translucent skin pheno-
type on the 3rd instar, and all the positive mutations were
allowed to develop to the moths.
T7 endonuclease I assay
In vitro transcribed TALEN-702 mRNA were microinjected
into about 100 silkworm embryos. Genomic DNA was
extracted from injected embryos using standard phenol/
chloroform method. The genomic region encompassing
TALEN-702 target site was amplified using primers
702-F883 and 702-R611 (Table S2). The PCR product was
treated 5 units of T7 endonuclease 1 (NEB) for 15 min at
37°C and then precipitated by addition of 2.5 volumes of
ethanol. The precipitated DNA was analyzed by agarose
gel electrophoresis. Genomic DNA from un-injected em-
bryos was used as control.
Design and synthesis of ssODN
The ssODN was designed as described by Chen et al.
[17] and synthesized using a commercial service
(Genescript). The ssODN was dissolved in RNAse-free
water (Sigma-Aldrich) at 100 mM and mixed with cor-
responding TALEN mRNA for microinjection.
Sequencing of the mutations
PCR products were inserted into a T-vector (TransGen) and
sequenced using a commercial service (Beijing Genomics
Institute). The methods used for PCR and T-cloningwere followed standard molecular cloning protocols and
the instructions provided by the manufacturers.
Additional file
Additional file 1: Figure S1. Chromosomal deletions using TALEN-B3
and B3-794. M represents the DNA ladders, the letters on the left indicate
length of each band. The numbers at the top of each panel represent
the silkworm hatched from embryos injected with B3 mRNA and ssODN.
The main band is from the native BmBlos2 locus with or without the
B3-induced small modifications. The expected bands were about 556 bp
if large deletions occurred. The numbers at the bottom represent the
relative frequencies of large deletions. Table S1. Microinjection of TALEN
and ssODN into the embryo of Dazao. Table S2. Primers and
oligodeoxynucleotides used in this study.
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